{
  "query": "What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases?",
  "keqe_expansions": [
    "The inflammatory response and pathogenesis of COVID-19 cases involve a complex interplay of immune cells and molecules in the body. When the SARS-CoV-2 virus enters the respiratory tract, it infects and replicates within the cells, triggering an immune response. The virus activates the innate immune system, leading to the release of pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-\u03b1), and interleukin-1 beta (IL-1\u03b2).\n\nThis excessive release of pro-inflammatory cytokines results in a phenomenon known as a cytokine storm, which can cause widespread inflammation and tissue damage throughout the body. The immune system also recruits immune cells such as neutrophils and macrophages to the site of infection to help fight the virus. However, in severe cases of COVID-19, this inflammatory response can become dysregulated, leading to hyperinflammation and tissue damage.\n\nThe pathogenesis of COVID-19 involves not only the direct effects of the virus on the body but also the dysregulated immune response that can contribute to severe disease outcomes. Understanding the mechanism of the inflammatory response in COVID-19 cases is crucial for developing effective treatments and interventions to mitigate the impact of the disease.",
    "During COVID-19 infection, the inflammatory response and pathogenesis are primarily driven by the body's immune system reacting to the presence of the virus, SARS-CoV-2. The virus enters the body through respiratory droplets and gains access to the cells lining the airways. Here, the virus hijacks the host cell machinery to replicate, leading to cell damage and viral spread. This viral replication triggers the release of pro-inflammatory cytokines and chemokines, initiating the body's immune response.\n\nIn some cases, an overactive immune response occurs, leading to a phenomenon known as a cytokine storm. This cytokine storm can cause widespread inflammation and tissue damage in various organs, particularly the lungs. The excessive inflammation can result in acute respiratory distress syndrome (ARDS) and other complications, contributing to the severity of the disease.\n\nFurthermore, the virus can directly infect endothelial cells, causing endothelial dysfunction and promoting a pro-coagulant state. This can lead to microvascular thrombosis and vascular damage, exacerbating the inflammatory response and contributing to the development of blood clots seen in severe cases of COVID-19.\n\nOverall, the inflammatory response in COVID-19 is a complex interplay between the virus, the host immune system, and various factors contributing to tissue damage and disease pathogenesis. Understanding these mechanisms is crucial for developing effective treatments and interventions for managing severe cases of COVID-19."
  ],
  "csqe_expansions": [
    "What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases, Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy? COVID-19 Hyperinflammation: What about Neutrophils? A dynamic immune response shapes COVID-19 progression A Dynamic Immune Response Shapes COVID-19 Progression Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019. In  , the overexpression of delayed rectifier K+-channels (Kv1.3) in leukocytes is responsible for the overactivation of cellular immunity and the subsequent cytokine storm. COVID-19 is often related to hyperinflammation that drives lung or multiorgan injury. The inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis. Cytokine analyses of whole blood revealed increased cytokine expression in the single most severe case. Given that inflammatory immune cells may induce severe lung injury, the involvement of immune factors in the pathogenesis of the disease cannot be overestimated.",
    "What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases? targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19... overexpression of delayed rectifier K+-channels (Kv1.3) in leukocytes is responsible for the overactivation of cellular immunity and the subsequent cytokine storm. In our previous basic studies, drugs including chloroquine and azithromycin strongly suppressed the channel activity and pro-inflammatory cytokine production from lymphocytes. These findings suggest a novel pharmacological mechanism by which chloroquine, with or without azithromycin, is effective for severe cases of COVID-19. The inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis. Parallel analyses of CD4 and CD8 expression suggested that the pro-inflammatory response may be intertwined with T-cell activation. the involvement of immune factors in the pathogenesis of the disease cannot be overestimated. it has been demonstrated that coronaviruses (CoVs) have developed mechanisms of immune evasion, making them invisible to the immune system at an early stage of infection."
  ],
  "top_passages": [
    "Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?\tIn the midst of a pandemic, finding effective treatments for coronavirus disease 2019 (COVID-19) is the urgent issue. In \"chronic inflammatory diseases\", the overexpression of delayed rectifier K+-channels (Kv1.3) in leukocytes is responsible for the overactivation of cellular immunity and the subsequent cytokine storm. In our previous basic studies, drugs including chloroquine and azithromycin strongly suppressed the channel activity and pro-inflammatory cytokine production from lymphocytes. These findings suggest a novel pharmacological mechanism by which chloroquine, with or without azithromycin, is effective for severe cases of COVID-19, in which the",
    "COVID-19 Hyperinflammation: What about Neutrophils?\tCOVID-19 is often related to hyperinflammation that drives lung or multiorgan injury. The immunopathological mechanisms that cause excessive inflammation are under investigation and constantly updated. Here, a gene network approach was used on recently published data sets to identify possible COVID-19 inflammatory mechanisms and bioactive genes. First, network analysis of putative SARS-CoV-2 cellular receptors led to the mining of a neutrophil-response signature and relevant inflammatory genes. Second, analysis of RNA-seq data sets of lung cells infected with SARS-CoV-2 revealed that infected cells expressed neutrophil-attracting chemokines. Third, analysis of RNA-seq data sets of bronchoalveolar lavage fluid cells from COVID-19 patients",
    "A dynamic immune response shapes COVID-19 progression\tThe inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis We conducted daily transcriptomic profiling of three COVID-19 cases and found that the early immune response in COVID-19 patients is highly dynamic Patient throat swabs were tested daily for SARS-CoV-2 with the virus persisting for 3-4 weeks in all three patients Cytokine analyses of whole blood revealed increased cytokine expression in the single more severe case However, most inflammatory gene expression peaked after respiratory function nadir, except those in the IL1 pathway Parallel analyses of CD4 and CD8 expression suggested that the pro-inflammatory response may be intertwined with T-cell activation that",
    "A Dynamic Immune Response Shapes COVID-19 Progression\tThe inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis. We conducted daily transcriptomic profiling of three COVID-19 cases and found that the early immune response in COVID-19 patients is highly dynamic. Patient throat swabs were tested daily for SARS-CoV-2, with the virus persisting for 3 to 4 weeks in all three patients. Cytokine analyses of whole blood revealed increased cytokine expression in the single most severe case. However, most inflammatory gene expression peaked after respiratory function nadir, except expression in the IL1 pathway. Parallel analyses of CD4 and CD8 expression suggested that the pro-inflammatory response may be intertwined",
    "Dupilumab and COVID\u201019: What should we expect?\tCoronavirus disease 2019 (COVID\u201019) is a pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) with high morbidity and mortality. There are very limited data on the interference of immunomodulating drugs on the risk of infection and on the course of the disease. In particular, there are no current clinical data about the interference exerted by dupilumab, a biologic drugs blocking IL\u20104 and IL\u201013, used for adult atopic dermatitis. The pathogenesis of COVID\u201019 is complex, characterized by an immune response mainly Th1/Th17. The hyper\u2010activation of these cells may cause the release of pro\u2010inflammatory cytokines that may result in lung impairment. IL\u20104",
    "Dupilumab and COVID-19: What should we expect?\tCoronavirus disease 2019 (COVID-19) is a pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high morbidity and mortality. There are very limited data on the interference of immunomodulating drugs on the risk of infection and on the course of the disease. In particular, there are no current clinical data about the interference exerted by dupilumab, a biologic drugs blocking IL-4 and IL-13, used for adult atopic dermatitis. The pathogenesis of COVID-19 is complex, characterized by an immune response mainly Th1/Th17. The hyper-activation of these cells may cause the release of pro-inflammatory cytokines that may",
    "Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients With COVID-19: A Review of the Current Evidence and Our Surgical Experience\tMounting evidence suggests that the pathogenesis of coronavirus disease 2019 (COVID-19) involves a hyperinflammatory response predisposing patients to thromboembolic disease and acute respiratory distress. In the setting of severe blunt trauma, damaged tissues induce a local and systemic inflammatory response through similar pathways to COVID-19. As such, patients with COVID-19 sustaining orthopaedic trauma injuries may have an amplified response to the traumatic insult because of their baseline hyperinflammatory and hypercoagulable states. These patients may have compromised physiological reserve to withstand the insult of surgical intervention before reaching clinical instability. In this article, we review",
    "Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience\tMounting evidence suggests that the pathogenesis of coronavirus disease 2019 (COVID-19) involves a hyperinflammatory response predisposing patients to thromboembolic disease and acute respiratory distress. In the setting of severe blunt trauma, damaged tissues induce a local and systemic inflammatory response through similar pathways to COVID-19. As such, patients with COVID-19 sustaining orthopaedic trauma injuries may have an amplified response to the traumatic insult due to their baseline hyperinflammatory and hypercoagulable state. These patients may have compromised physiological reserve to withstand the insult of surgical intervention before reaching clinical instability. Herein, we review the current",
    "Cytochrome P450-mediated drug interactions in COVID-19 patients: current findings and possible mechanisms\tAt the end of 2019, the entire world has witnessed the birth of a new member of coronavirus family in Wuhan, China. Ever since, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has swiftly invaded every corner on the planet. By the end of April 2020, almost 3.5 million cases have been reported worldwide, with a death toll of about 250000 deaths. It is currently well-recognized that patient\u2019s immune response plays a pivotal role in the pathogenesis of Coronavirus Disease 2019 (COVID-19). This inflammatory element was evidenced by its elevated mediators that, in",
    "Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.\tNovel coronavirus disease-2019 (COVID-19) is a highly contagious respiratory-related disease induced by the newly emerged virus SARS-CoV-2. Given that inflammatory immune cells may induce severe lung injury, the involvement of immune factors in the pathogenesis of the disease cannot be overestimated. It has been demonstrated that coronaviruses (CoVs) have developed mechanisms of immune evasion, making them invisible to the immune system at an early stage of infection. The mechanism relies on inhibition of the anti-viral response of type I interferons (IFNs), which supports uncontrolled viral replication in epithelial cells"
  ],
  "combined_expansion": "What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases? What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases? The inflammatory response and pathogenesis of COVID-19 cases involve a complex interplay of immune cells and molecules in the body. When the SARS-CoV-2 virus enters the respiratory tract, it infects and replicates within the cells, triggering an immune response. The virus activates the innate immune system, leading to the release of pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-\u03b1), and interleukin-1 beta (IL-1\u03b2).\n\nThis excessive release of pro-inflammatory cytokines results in a phenomenon known as a cytokine storm, which can cause widespread inflammation and tissue damage throughout the body. The immune system also recruits immune cells such as neutrophils and macrophages to the site of infection to help fight the virus. However, in severe cases of COVID-19, this inflammatory response can become dysregulated, leading to hyperinflammation and tissue damage.\n\nThe pathogenesis of COVID-19 involves not only the direct effects of the virus on the body but also the dysregulated immune response that can contribute to severe disease outcomes. Understanding the mechanism of the inflammatory response in COVID-19 cases is crucial for developing effective treatments and interventions to mitigate the impact of the disease. During COVID-19 infection, the inflammatory response and pathogenesis are primarily driven by the body's immune system reacting to the presence of the virus, SARS-CoV-2. The virus enters the body through respiratory droplets and gains access to the cells lining the airways. Here, the virus hijacks the host cell machinery to replicate, leading to cell damage and viral spread. This viral replication triggers the release of pro-inflammatory cytokines and chemokines, initiating the body's immune response.\n\nIn some cases, an overactive immune response occurs, leading to a phenomenon known as a cytokine storm. This cytokine storm can cause widespread inflammation and tissue damage in various organs, particularly the lungs. The excessive inflammation can result in acute respiratory distress syndrome (ARDS) and other complications, contributing to the severity of the disease.\n\nFurthermore, the virus can directly infect endothelial cells, causing endothelial dysfunction and promoting a pro-coagulant state. This can lead to microvascular thrombosis and vascular damage, exacerbating the inflammatory response and contributing to the development of blood clots seen in severe cases of COVID-19.\n\nOverall, the inflammatory response in COVID-19 is a complex interplay between the virus, the host immune system, and various factors contributing to tissue damage and disease pathogenesis. Understanding these mechanisms is crucial for developing effective treatments and interventions for managing severe cases of COVID-19. What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases, Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy? COVID-19 Hyperinflammation: What about Neutrophils? A dynamic immune response shapes COVID-19 progression A Dynamic Immune Response Shapes COVID-19 Progression Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019. In  , the overexpression of delayed rectifier K+-channels (Kv1.3) in leukocytes is responsible for the overactivation of cellular immunity and the subsequent cytokine storm. COVID-19 is often related to hyperinflammation that drives lung or multiorgan injury. The inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis. Cytokine analyses of whole blood revealed increased cytokine expression in the single most severe case. Given that inflammatory immune cells may induce severe lung injury, the involvement of immune factors in the pathogenesis of the disease cannot be overestimated. What is the mechanism of inflammatory response and pathogenesis of COVID-19 cases? targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19... overexpression of delayed rectifier K+-channels (Kv1.3) in leukocytes is responsible for the overactivation of cellular immunity and the subsequent cytokine storm. In our previous basic studies, drugs including chloroquine and azithromycin strongly suppressed the channel activity and pro-inflammatory cytokine production from lymphocytes. These findings suggest a novel pharmacological mechanism by which chloroquine, with or without azithromycin, is effective for severe cases of COVID-19. The inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis. Parallel analyses of CD4 and CD8 expression suggested that the pro-inflammatory response may be intertwined with T-cell activation. the involvement of immune factors in the pathogenesis of the disease cannot be overestimated. it has been demonstrated that coronaviruses (CoVs) have developed mechanisms of immune evasion, making them invisible to the immune system at an early stage of infection."
}